By
Jeff Dale2025-01-17T15:49:00
Cannabis hedge fund Navy Capital Green Management agreed to pay $150,000 to settle charges levied by the Securirties and Exchange Commission (SEC) that the firm misled investors about its anti-money laundering/countering the financing of terrorism (AML/CFT) policies and allowed a sanctioned Russian oligarch to invest.
Navy Capital told investors it abided by strict AML/CFT due diligence policies despite actual due diligence practices being materially inconsistent with its representations, the SEC alleged in an order Tuesday.
Between at least October 2018 and January 2022, Navy Capital represented it “conducted specific AML due diligence on prospective investors and ongoing AML due diligence monitoring on existing investors,” including “confirming the identity of the investor and its principal beneficial owners,” the order said.
2025-06-13T14:39:00Z By Aaron Nicodemus
A San Francisco venture capital firm will pay a $216 million fine to the U.S. Treasury for violating U.S. sanctions by managing investments for a Russian oligarch.
2025-01-10T20:14:00Z By Adrianne Appel
A cannabis company agreed to pay $225,000 to settle allegations that funds were temporarily deposited into its year-end accounts for the sole purpose of inflating year-end cash, the Securities and Exchange Commission said.
2024-09-20T15:38:00Z By Jeff Dale
A “biblically responsible” investment adviser agreed to pay $300,000 and hire an independent compliance consultant to settle charges with the Securities and Exchange Commission that it misled investors, along with other compliance failures.
2025-11-05T18:35:00Z By Oscar Gonzalez
Approximately $9 billion of potential shadow-banking flows tied to Iranian networks in 2024, according to a new analysis from FinCEN. The report highlights how illicit funds are making their way through financial institutions as they meet the requirements of the Bank Secrecy Act (BSA).
2025-10-31T18:52:00Z By Oscar Gonzalez
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
2025-10-30T19:59:00Z By Oscar Gonzalez
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
Site powered by Webvision Cloud